Articles

Hawkeyeish on technology

DNASTAR and the University of Iowa sign Lasergene site license agreement
| 3 min read

MADISON, Wis.—DNASTAR, a molecular biology software company, announced recently that researchers at the University of Iowa have signed a broad site license agreement for the use of its Lasergene sequence analysis software.

Under the terms of the site license, University of Iowa researchers will have unlimited access and use of the software for their sequence analysis projects. The license is for a four-year period. Financial terms of the agreement were not released.

According to Tom Schwei, vice president, general manager and CFO of DNASTAR, the Lasergene site license covers the entire Iowa City campus, and researchers from a wide range of disciplines will have access to the software.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Top view of a laboratory researcher wearing green gloves and using a pipette to transfer liquid at a bench surrounded by other laboratory equipment.
​​​​​Repetitive pipetting can strain the hands, wrists, shoulders, and neck, making ergonomics an important part of efficient liquid handling.
A gloved hand holds two glass microscope slides containing pink-stained tissue sections in a laboratory setting.
See how advanced slide-based imaging connects tissue architecture with cellular detail across fluorescent and histological samples.
Illustration of brightly coloured pink and purple cells floating against a blue background.
Explore how high-dimensional flow cytometry can expand immune profiling and support immunotoxicology assessment during preclinical drug development.